STOCK TITAN

Olink to participate in September investor conferences

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) will participate in several upcoming investor conferences. The schedule includes the Goldman Sachs Medtech and Healthcare Services Conference on September 7 at 6:30 am ET, the Morgan Stanley Healthcare Conference on September 12 at 11:40 am ET, and the Nordea Life Science Tools Day on September 21 at 9:30 am ET. Webcasts of the events will be available in the 'Events' section of the company's website. Olink focuses on advancing proteomics in partnership with the scientific community to enhance patient outcomes.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OLK

+0.27%
+0.27% Session move

In the trading session that priced this news, OLK gained 0.27%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UPPSALA, Sweden, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor conferences:

  • Goldman Sachs Medtech and Healthcare Services Conference
    Wednesday, September 7th at 6:30 am ET
  • Morgan Stanley Healthcare Conference
    Monday, September 12th at 11:40 am ET
  • Nordea Life Science Tools Day
    Wednesday, September 21st at 9:30 am ET

A live and archived webcast of the events will be available on the “Events” section of the Company’s website at https://investors.olink.com/news-events/events.

About Olink
Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

IR contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com  

Media contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com


FAQ